Search

everythinglearnresearchcommunity

for

Search:↓

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

The market for these drugs is expected to grow.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Imuvert can prevent some chemotherapy-induced hair loss.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Dutasteride is approved to help manage prostate enlargement.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Nanoparticles around 600-700 nm can effectively enter and stay in hair follicles for days, which may help in delivering drugs to specific cells.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Obese women with PCOS are more likely to have fatty liver disease.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Micro-segmental hair analysis helps detect drug use patterns and estimate drug consumption days.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

HIV patients with lower CD4 T cell counts often have more skin problems.